No icon

Passion IT Framework

Case Study Describes Cancer Immunotherapy Opdivo Leading to LEMS

A case report describes Lambert-Eaton myasthenic syndrome (LEMS) and cerebellar degeneration — deterioration in the cerebellum, a key brain area for balance and coordination — in a woman with neuroendocrine cancer, likely induced by Opdivo (nivolumab) treatment.  

Read More at:

https://lamberteatonnews.com/news-posts/2020/12/17/case-study-cancer-immunotherapy-opdivo-leading-to-lems/

Comment


TOP